Loading clinical trials...

Effects of Shenkang Decoction on Creatinine and Blood Urea Nitrogen in Chronic Renal Failure Hemodialysis Patients | Clinical Trials | Clareo Health

COMPLETEDEARLY_PHASE1

Effects of Shenkang Decoction on Creatinine and Blood Urea Nitrogen in Chronic Renal Failure Hemodialysis Patients

Effects of Shenkang Decoction on Creatinine and Blood Urea Nitrogen in Chronic Renal Failure Hemodialysis Patients: A Randomized Controlled Trial

NCT05631782•The First People's Hospital of Zunyi

View on ClinicalTrials.gov

Summary

To explore the clinical effect of Shenkang Decoction in chronic renal failure (CRF) patients with hemodialysis (HD).

Eligibility

Age

52 - 65 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•The diagnosis of western medicine meets the diagnostic criteria of chronic kidney failure in Internal Medicine
•the diagnosis of TCM meets the diagnostic criteria of the disease in the Guiding Principles for Clinical Research of New Chinese Medicine.
•The patient is over 18 years old,
•can think independently and have civil conduct,
•strictly follow the doctor's advice,
•maintain stable condition and regular HD treatment.

Exclusion Criteria

•Patients with HD time of no more than three months, severe uncontrolled infection, other malignant diseases, heart, liver, brain, and digestive system dysfunction, mental diseases such as dementia or depression;
•contraindications to HD or contraindications to the study (Shock or systolic blood pressure below 80mm/Hg, severe bleeding or a tendency to bleed, serious infection such as sepsis, or a blood-borne infection, advanced tumor, extremely debilitating or not cooperating with doctor)
•drug allergy, chronic use of glucocorticoids, and immunosuppressants.
•women during pregnancy or lactation.

Locations (1)

The First People's Hospital of Zunyi

Zunyi, China

Key Dates

Start Date

November 10, 2020

Primary Completion Date

December 25, 2021

Completion Date

December 26, 2021

Last Updated

November 30, 2022

Enrollment

160

ACTUAL participants

Conditions

Chronic Renal FailureHemodialysis

Interventions

Shenkang decoction

DRUG

The Effectiveness of Education in Diabetic Hemodialysis Patients

NCT07462741

Hemodialysis PatientDiabetes Foot Care

View study

RECRUITINGNA

Using a Hypotension Prediction Index to Prevent Low Blood Pressure During Dialysis in ICU Patients

NCT07179705

Intradialytic HypotensionIntensive Care Unit ICU+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 30, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Effects of Shenkang Decoction on Creatinine and Blood Urea Nitrogen in Chronic Renal Failure Hemodialysis Patients

Inclusion Criteria

Exclusion Criteria

The Effectiveness of Education in Diabetic Hemodialysis Patients

Using a Hypotension Prediction Index to Prevent Low Blood Pressure During Dialysis in ICU Patients

Predictive Value of Carotid Ultrasonography for Intradialytic Hypotension

Effect of a Structured Physical Exercise Program on Arteriovenous Fistula Maturation for Hemodialysis in Chronic Kidney Disease Patients

Effects of Royal Jelly Supplementation in Chronic Kidney Disease

Acoustic Analysis of VA Sounds